{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:09:41Z","timestamp":1770066581414,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.anndiagpath.2020.151558","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T07:09:32Z","timestamp":1592636972000},"page":"151558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India"],"prefix":"10.1016","volume":"47","author":[{"given":"Bharat","family":"Rekhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedar K.","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151558_bb0005","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/annonc\/mdw542","article-title":"Practical guidance for mismatch repair-deficiency testing in endometrial cancer","volume":"28","author":"Stelloo","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0020","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1097\/PAS.0b013e318237c6ab","article-title":"\u201cNull pattern\u201d of immunoreactivity in a lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation","volume":"35","author":"Hagen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5858\/arpa.2012-0654-RA","article-title":"Endometrial carcinoma in women aged 40 years and younger","volume":"138","author":"Garg","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0030","doi-asserted-by":"crossref","unstructured":"Pasanen A, Loukovaara M, B\u00fctzow R. Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma. Mod Pathol Feb 14. doi: https:\/\/doi.org\/10.1038\/s41379-020-0501-8. [Epub ahead of print].","DOI":"10.1038\/s41379-020-0501-8"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2013.08.003","article-title":"MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome","volume":"131","author":"Nelson","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2018.08.020","article-title":"Does MMR status in endometrial cancer influence response to adjuvant therapy?","volume":"151","author":"Kim","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/PGP.0000000000000099","article-title":"The immunohistochemistry signature of mismatch repair (MMR) proteins in a multiethnic Asian cohort with endometrial carcinoma","volume":"33","author":"Woo","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317725834","article-title":"Prevalence and prognostic role of mismatch repair gene defect in endometrial cancer patients","volume":"39","author":"Tangjitgamol","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4103\/0377-4929.168859","article-title":"Mismatch repair protein deficient endometrioid adenocarcinomas, metastasizing to adrenal gland and lymph nodes: unusual cases with diagnostic implications","volume":"58","author":"Rekhi","year":"2015","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0060","first-page":"7297","article-title":"Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families","volume":"7","author":"Long","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0065","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/jog.14061","article-title":"Usefulness of immunohistochemistry for mismatch repair protein and microsatellite instability examination in adenocarcinoma and background endometrium of sporadic endometrial cancer cases","volume":"45","author":"Saeki","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0070","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/PGP.0000000000000518","article-title":"Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological Pathologists","volume":"38","author":"Soslow","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"Suppl. 8","key":"10.1016\/j.anndiagpath.2020.151558_bb0075","doi-asserted-by":"crossref","first-page":"viii342","DOI":"10.1093\/annonc\/mdy285.163","article-title":"Prevalence and clinical implications of mismatch repair (MMR) deficiency in unselected endometrial cancer (EC) patients","volume":"29","author":"Aguilar","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0080","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.3802\/jgo.2018.29.e39","article-title":"Australian Endometrial Cancer Study Group. Endometrial cancer risk and survival by tumor MMR status","volume":"29","author":"Nagle","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10689-007-9145-9","article-title":"The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside","volume":"7","author":"Boland","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0090","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1200\/JCO.2006.06.7173","article-title":"Molecular and pathologic aspects of endometrial carcinogenesis","volume":"24","author":"Hecht","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0095","first-page":"183","article-title":"Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome)","volume":"7","author":"Buchanan","year":"2014","journal-title":"Appl Clin Genet"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151558_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090279","article-title":"DNA mismatch repair protein immunohistochemistry and MLH1 Promotor methylation testing for practical molecular classification andthe prediction of prognosis in endometrial Cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0022-3859.150444","article-title":"An audit of histopathology reports of carcinoma endometrium: experience from a tertiary referral center","volume":"61","author":"Deodhar","year":"2015","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0110","unstructured":"National comprehensive cancer network (NCCN) guidelines version 1.2020. Uterine neoplasms. P. 1\u2013108. https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#site."},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.semdp.2010.09.003","article-title":"Endometrial carcinomas with ambiguous features","volume":"27","author":"Soslow","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1066896909332117","article-title":"Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types","volume":"18","author":"Carcangiu","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2011.06.005","article-title":"Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40 years of age and younger","volume":"123","author":"Shih","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.13471","article-title":"Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000085","article-title":"Frequent expression of napsin a in clear cell carcinoma of the endometrium: potential diagnostic utility","volume":"38","author":"Fadare","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"10.1016\/j.anndiagpath.2020.151558_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153744","article-title":"Dedifferentiated endometrial carcinoma could be a target for immune checkpoint inhibitors (anti PD-1\/PD-L1 antibodies)","volume":"20","author":"Ono","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","article-title":"Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability","volume":"36","author":"Aysal","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0160","first-page":"1387","article-title":"Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium","volume":"9","author":"Shannon","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0165","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2013.12.003","article-title":"Mismatch repair deficiency in ovarian cancer -- molecular characteristics and clinical implications","volume":"132","author":"Xiao","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2009.12.028","article-title":"Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer","volume":"117","author":"Resnick","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0175","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151558_bb0180","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2011.75","article-title":"Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma","volume":"24","author":"Steinbakk","year":"2011","journal-title":"Mod Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:17Z","timestamp":1761078737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"alternative-id":["S1092913420301015"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151558","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151558"}}